These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34088416)

  • 1. My Treatment Approach to Giant Cell Arteritis.
    Garvey TD; Koster MJ; Warrington KJ
    Mayo Clin Proc; 2021 Jun; 96(6):1530-1545. PubMed ID: 34088416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
    Hellmich B; Águeda AF; Monti S; Luqmani R
    Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapses in giant cell arteritis: Updated review for clinical practice.
    Alba MA; Kermani TA; Unizony S; Murgia G; Prieto-González S; Salvarani C; Matteson EL
    Autoimmun Rev; 2024 Jun; 23(6):103580. PubMed ID: 39048072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Giant Cell Arteritis.
    Guevara M; Kollipara CS
    Curr Rheumatol Rep; 2018 Apr; 20(5):25. PubMed ID: 29611005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of biologics in the treatment of giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of giant cell arteritis - current approach and new possibilities].
    Videman J; Skácelová M; Horák P; Skoumalová A; Hraboš D
    Vnitr Lek; 2022; 68(5):266-272. PubMed ID: 36283815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of giant cell arteritis: what is in the pipeline?].
    Holle JU; Moosig F
    Z Rheumatol; 2020 Aug; 79(6):516-522. PubMed ID: 32399619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of giant cell arteritis.
    González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
    Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyalgia Rheumatica and Giant Cell Arteritis.
    Buttgereit F; Matteson EL; Dejaco C
    JAMA; 2020 Sep; 324(10):993-994. PubMed ID: 32897333
    [No Abstract]   [Full Text] [Related]  

  • 14. Giant cell arteritis.
    Pepper K
    Postgrad Med; 2023 Jan; 135(sup1):22-32. PubMed ID: 37021621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
    Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
    Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM
    Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on giant cell arteritis.
    Sammel AM; Fraser CL
    Curr Opin Ophthalmol; 2018 Nov; 29(6):520-527. PubMed ID: 30138144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in the Diagnosis and Management of Giant Cell Arteritis.
    Uppal S; Hadi M; Chhaya S
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):68. PubMed ID: 31396718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell arteritis: epidemiology, diagnosis, and management.
    Gonzalez-Gay MA; Martinez-Dubois C; Agudo M; Pompei O; Blanco R; Llorca J
    Curr Rheumatol Rep; 2010 Dec; 12(6):436-42. PubMed ID: 20857242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approach to giant cell arteritis.
    Masson C
    Joint Bone Spine; 2012 May; 79(3):219-27. PubMed ID: 22119350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.